(Q56981562)

1

0 references

author name string

Luciano Merlini

1

0 references

Monia Gennari

2

0 references

Elisabetta Malaspina

3

0 references

Ilaria Cecconi

4

0 references

Annarita Armaroli

5

0 references

Saverio Gnudi

6

0 references

Beril Talim

7

0 references

Alessandra Ferlini

8

0 references

Alessandro Cicognani

9

0 references

Emilio Franzoni

Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

10

0 references

language of work or name

English

0 references

publication date

June 2012

0 references

11 May 2012

0 references

published in

Muscle and Nerve

0 references

volume

45

0 references

issue

6

0 references

page(s)

796-802

0 references

cites work

1 reference

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management

21 January 2018

1 reference

Deflazacort for the treatment of Duchenne Dystrophy: a systematic review

21 January 2018

1 reference

Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management

21 January 2018

1 reference

Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect

21 January 2018

1 reference

Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade.

21 January 2018

1 reference

Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy

21 January 2018

1 reference

Deflazacort use in Duchenne muscular dystrophy: an 8-year follow-up

21 January 2018

1 reference

Vertebral compression in Duchenne muscular dystrophy following deflazacort

21 January 2018

1 reference

Remission of clinical signs in early duchenne muscular dystrophy on intermittent low-dosage prednisolone therapy

21 January 2018

1 reference

An effective, low-dosage, intermittent schedule of prednisolone in the long-term treatment of early cases of Duchenne dystrophy

21 January 2018

1 reference

Early prednisone treatment in Duchenne muscular dystrophy

21 January 2018

1 reference

Early treatment to preserve quality of locomotion for children with Duchenne muscular dystrophy.

21 January 2018

1 reference

Reliability of hand-held dynamometry in spinal muscular atrophy

21 January 2018

1 reference

Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr).

21 January 2018

1 reference

Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care

21 January 2018

1 reference

Deflazacort treatment of Duchenne muscular dystrophy

21 January 2018

1 reference

High dose weekly oral prednisone improves strength in boys with Duchenne muscular dystrophy.

21 January 2018

1 reference

Decline in respiratory function and experience with long-term assisted ventilation in advanced Duchenne's muscular dystrophy.

21 January 2018

1 reference

Effects of deflazacort on left ventricular function in patients with Duchenne muscular dystrophy

21 January 2018

1 reference

170th ENMC International Workshop: Bone protection for corticosteroid treated Duchenne muscular dystrophy. 27–29 November 2009, Naarden, The Netherlands

21 January 2018

1 reference

Growth hormone evaluation in Duchenne muscular dystrophy.

21 January 2018

1 reference

Relation between height and clinical course in Duchenne muscular dystrophy

21 January 2018

1 reference

Variations in the Pattern of Pubertal Changes in Boys

21 January 2018

1 reference

The role of corticosteroids in muscular dystrophy: a critical appraisal

21 January 2018

1 reference

Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy

21 January 2018

1 reference

Intermittent prednisone therapy in Duchenne muscular dystrophy: a randomized controlled trial

21 January 2018

1 reference